Variable expression of coxsackie-adenovirus receptor in thyroid tumors: Implications for adenoviral gene therapy

Derek K. Marsee, Douangsone D. Vadysirisack, Carl D. Morrison, Manju L. Prasad, Charis Eng, Quan Yang Duh, Katherine A Rauen, Richard T. Kloos, Sissy M. Jhiang

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Adenoviral gene therapy represents a novel approach for the treatment of aggressive thyroid carcinomas. Both coxsackie-adenovirus receptor (CAR) and integrins have been shown to be the major determinants for adenoviral infectivity in many types of cancer cells, yet conflicting results have been reported. In this report we examine these factors mediating adenoviral infection in thyroid cells and to evaluate CAR expression in various types of thyroid cancer. We found that neither expression levels of CAR nor integrins are solely predictive of adenoviral infectivity in thyroid cells. However, the absence of CAR was associated with poor adenoviral infectivity in immortalized rat FRTL-5 cells. Moreover, preincubation with α-CAR antibody decreased infectivity in FTC 238 cells, a human thyroid tumor line. These results indicate that CAR does play a role in adenoviral infection of thyroid cells. Immunohistochemical analysis revealed that CAR is expressed at the cell surface in the majority of malignant thyroid tumors. We further show that adenoviral infectivity in some thyroid cancer cells can be improved by poly-L-lysine. Our study warrants a functional method to evaluate adenoviral infectivity should be developed and instituted prior to clinical trials of adenoviral gene therapy in patients with advanced thyroid cancer.

Original languageEnglish (US)
Pages (from-to)977-987
Number of pages11
Issue number9
StatePublished - Sep 2005
Externally publishedYes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Variable expression of coxsackie-adenovirus receptor in thyroid tumors: Implications for adenoviral gene therapy'. Together they form a unique fingerprint.

Cite this